Exencial Wealth Advisors, LLC Vertex Pharmaceuticals Inc Transaction History

Exencial Wealth Advisors, LLC

$2.62 Billion
Q2 2024

A detailed history of Exencial Wealth Advisors, LLC transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Exencial Wealth Advisors, LLC holds 2,434 shares of VRTX stock, worth $1.15 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares

2,434

Previous 2,523 3.53%

Holding current value

$1.15 Million

Previous $1.05 Million 8.16%

% of portfolio

0.04%

Previous 0.04%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 12, 2024	SELL	$392.81 - $485.53 $34,960 - $43,212	-89 Reduced 3.53%	2,434 $1.14 Million
Q1 2024 May 10, 2024	SELL	$407.69 - $446.08 $89,284 - $97,691	-219 Reduced 7.99%	2,523 $1.05 Million
Q4 2023 Feb 13, 2024	SELL	$343.0 - $410.68 $188,993 - $226,284	-551 Reduced 16.73%	2,742 $1.12 Million
Q3 2023 Nov 08, 2023	SELL	$338.18 - $362.46 $130,199 - $139,547	-385 Reduced 10.47%	3,293 $1.15 Million
Q2 2023 Aug 10, 2023	SELL	$314.42 - $351.91 $210,346 - $235,427	-669 Reduced 15.39%	3,678 $1.29 Million
Q1 2023 May 02, 2023	SELL	$283.23 - $323.1 $192,029 - $219,061	-678 Reduced 13.49%	4,347 $1.37 Million
Q4 2022 Feb 14, 2023	SELL	$285.76 - $321.48 $8.54 Million - $9.6 Million	-29,875 Reduced 85.6%	5,025 $1.45 Million
Q3 2022 Nov 08, 2022	SELL	$273.83 - $305.53 $322,024 - $359,303	-1,176 Reduced 3.26%	34,900 $10.1 Million
Q2 2022 Aug 11, 2022	SELL	$234.96 - $292.55 $663,527 - $826,161	-2,824 Reduced 7.26%	36,076 $10.2 Million
Q1 2022 May 12, 2022	BUY	$221.42 - $260.97 $239,797 - $282,630	1,083 Added 2.86%	38,900 $10.2 Million
Q4 2021 Feb 10, 2022	BUY	$177.01 - $223.45 $214,713 - $271,044	1,213 Added 3.31%	37,817 $8.31 Million
Q3 2021 Nov 04, 2021	BUY	$181.39 - $202.99 $2.71 Million - $3.03 Million	14,923 Added 68.83%	36,604 $6.64 Million
Q2 2021 Aug 16, 2021	BUY	$187.49 - $221.1 $518,972 - $612,004	2,768 Added 14.64%	21,681 $4.37 Million
Q1 2021 May 06, 2021	BUY	$207.02 - $241.31 $1.04 Million - $1.21 Million	5,001 Added 35.95%	18,913 $4.06 Million
Q4 2020 Feb 11, 2021	BUY	$207.01 - $276.09 $2.88 Million - $3.84 Million	13,912 New	13,912 $3.29 Million
Q3 2020 Nov 13, 2020	SELL	$255.65 - $303.1 $176,909 - $209,745	-692 Closed	0 $0
Q2 2020 Aug 17, 2020	BUY	$225.48 - $295.8 $156,032 - $204,693	692 New	692 $201,000

Others Institutions Holding VRTX

# of Institutions

1,707

Shares Held

226M

Call Options Held

1.2M

Put Options Held

1.59M

View Full List

About VERTEX PHARMACEUTICALS INC

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $122B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

More about VRTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Exencial Wealth Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Exencial Wealth Advisors, LLC with notifications on news.

Account

Exencial Wealth Advisors, LLC Vertex Pharmaceuticals Inc Transaction History